Delivery Order SPE2DB22D2206-SPE2DB23FKC45
Award Date 9/5/23
Potential Completion Date 9/26/23
Potential Value $3.4K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $20,177 to Amerisourcebergen Drug Corporation to supply 4561689566 EXJADE 500 MG TABLET 30S. The order was issued against an indefinite delivery/indefinite quantity contract vehicle and will be performed in Conshohocken, Pennsylvania over a three week period concluding in mid-August. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will serve as the prime...
- The Defense Logistics Agency awarded a $6,761 firm fixed price delivery order to Amerisourcebergen Drug Corporation to supply 4562256402 EXJADE 125 MG TABLETS. The order is for 30 tablets to be delivered to a location in Conshohocken, Pennsylvania by October 6, 2023, with performance starting on September 15. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will serve as the prime contractor. No major subcontractors or set aside designations were...
- The Defense Logistics Agency awarded a $15,141.56 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561812938 EXJADE 500 MG TABLET 30S. The prime contractor, Amerisourcebergen Drug Corporation, is a division of Amerisourcebergen Corporation and will perform under the contract at its location in Conshohocken, Pennsylvania. The contract runs from August 10, 2023 through August 31, 2023 to supply the Defense Logistics Agency with the specified pharmaceutical product. No set...
- The Defense Logistics Agency awarded a $6,725.64 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561901159 EXJADE 500 MG TABLET 30S. The prime contractor, Amerisourcebergen Drug Corporation, will deliver the pharmaceutical product from its Conshohocken, Pennsylvania location to the Defense Logistics Agency by September 7, 2023. No subcontractors or set aside designations were indicated. The Defense Logistics Agency manages the global supply chain for the United...
- The Defense Logistics Agency issued a $22,197.65 delivery order to Amerisourcebergen Drug Corp on May 6, 2026, for Exjade 500 mg tablets (30-count supply) with an ultimate completion date of May 28, 2026. Place of performance is Conshohocken, PA. The order is priced on a firm fixed-price basis with no set-aside applied. Amerisourcebergen Drug Corp is a pharmaceutical distributor and medical supplier subsidiary of Cencora, Inc., competing on full-and-open competitive awards for Defense Health...
- The Defense Logistics Agency Troop Support Medical awarded a $3,356.42 firm fixed price delivery order to Amerisourcebergen Drug Corp for EXJADE 250 MG TABLET 30S. The order is for the delivery of pharmaceutical products to the agency's location in Conshohocken, Pennsylvania by November 2, 2023. Amerisourcebergen Drug Corp is a division of Amerisourcebergen Corporation, which will perform as the prime contractor. No set-aside designation was used for this award to support the Defense Logistics...
- This delivery order for $8,415.92, awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corporation, is for 4562667144 Exjade 500 mg tablets (30 tablets per package) to be delivered by November 15, 2023. The contract has a firm fixed price and will be performed by Amerisourcebergen in Conshohocken, Pennsylvania. No set-aside designation was used for this award placed against an existing vehicle by the Defense Logistics Agency to procure pharmaceutical products in support of military...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $10,206.51 to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, for the supply of EXJADE 500 MG TABLET 30S. This order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as Amerisourcebergen Drug Corp's primary vehicle for delivering pharmaceutical products and medical supplies to DLA Troop Support Medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,176.86 firm fixed-price delivery order is for the supply of EXJADE 500 MG TABLET 30S, a specialty pharmaceutical product. The contract has an ultimate completion date of December 13, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order valued at $6,725.64 by the Defense Logistics Agency (DLA) Troop Support Medical to supply 4562900204 EXJADE 500 MG TABLET 30S. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products from its headquarters in Conshohocken, Pennsylvania by December 8, 2023. No set-aside designation was applied to this contract award issued against an indefinite-delivery vehicle. Amerisourcebergen currently...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB23FKC45Delivery Order
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $3,363 to Amerisourcebergen Drug Corporation to supply 30 bottles of Exjade 500 mg tablets. The order is to be performed in Conshohocken, Pennsylvania by September 26, 2023 with Amerisourcebergen Corporation as the prime contractor. The Defense Logistics Agency manages the global supply chain for the U.S. military and supports numerous defense programs, indicating this order is likely to supply pharmaceutical products for DOD medical treatment facilities. No subcontractors or set aside designations were identified in the award information.
Generated 12/20/23, 11:38 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 9/5/23 |